| pubmed-article:6759059 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C1969581 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0002502 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0010581 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0020261 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0032821 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0040233 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0547040 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:6759059 | lifeskim:mentions | umls-concept:C0128814 | lld:lifeskim |
| pubmed-article:6759059 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6759059 | pubmed:dateCreated | 1983-3-24 | lld:pubmed |
| pubmed-article:6759059 | pubmed:abstractText | An open study was carried out in 641 patients with mild to moderate hypertension seen in general practice to assess the effectiveness of treatment with a timolol/hydrochlorothiazide/amiloride preparation compared with cyclopenthiazide/potassium. The timolol/hydrochlorothiazide/amiloride preparation produced better control of blood pressure in a larger percentage of patients after 2 and 6 weeks of treatment than did the diuretic/potassium preparation, and more patients were maintained on 1 tablet per day. Both treatments reduced the number of symptoms complained of by the patients at the initial visit. | lld:pubmed |
| pubmed-article:6759059 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6759059 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6759059 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6759059 | pubmed:issn | 0300-7995 | lld:pubmed |
| pubmed-article:6759059 | pubmed:author | pubmed-author:AshDD | lld:pubmed |
| pubmed-article:6759059 | pubmed:author | pubmed-author:YoungJJ | lld:pubmed |
| pubmed-article:6759059 | pubmed:author | pubmed-author:ParryE EEE | lld:pubmed |
| pubmed-article:6759059 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6759059 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:6759059 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6759059 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6759059 | pubmed:pagination | 253-9 | lld:pubmed |
| pubmed-article:6759059 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:meshHeading | pubmed-meshheading:6759059-... | lld:pubmed |
| pubmed-article:6759059 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6759059 | pubmed:articleTitle | Comparison of timolol/hydrochlorothiazide/amiloride ('Moducren') with cyclopenthiazide/potassium in mild to moderate hypertension. | lld:pubmed |
| pubmed-article:6759059 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6759059 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:6759059 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6759059 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
